東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/07/16 | 2,670 | 2,697 | 2,657 | 2,677 | +5 | +0.2% | 94,500 |
2021/07/15 | 2,689 | 2,703 | 2,661 | 2,672 | +5 | +0.2% | 105,800 |
2021/07/14 | 2,625 | 2,679 | 2,619 | 2,667 | +42 | +1.6% | 78,300 |
2021/07/13 | 2,580 | 2,633 | 2,572 | 2,625 | +76 | +3% | 169,300 |
2021/07/12 | 2,560 | 2,560 | 2,532 | 2,549 | +39 | +1.6% | 99,700 |
2021/07/09 | 2,495 | 2,521 | 2,462 | 2,510 | +3 | +0.1% | 138,000 |
2021/07/08 | 2,555 | 2,559 | 2,507 | 2,507 | -43 | -1.7% | 127,600 |
2021/07/07 | 2,569 | 2,582 | 2,518 | 2,550 | -119 | -4.5% | 243,900 |
2021/07/06 | 2,675 | 2,690 | 2,654 | 2,669 | -19 | -0.7% | 49,800 |
2021/07/05 | 2,735 | 2,737 | 2,683 | 2,688 | -62 | -2.3% | 98,700 |
2021/07/02 | 2,748 | 2,770 | 2,724 | 2,750 | +5 | +0.2% | 125,800 |
2021/07/01 | 2,704 | 2,749 | 2,674 | 2,745 | +41 | +1.5% | 110,400 |
2021/06/30 | 2,720 | 2,728 | 2,674 | 2,704 | -28 | -1% | 134,400 |
2021/06/29 | 2,765 | 2,765 | 2,719 | 2,732 | -25 | -0.9% | 120,900 |
2021/06/28 | 2,720 | 2,761 | 2,707 | 2,757 | +73 | +2.7% | 185,600 |
2021/06/25 | 2,680 | 2,689 | 2,654 | 2,684 | +29 | +1.1% | 82,800 |
2021/06/24 | 2,642 | 2,689 | 2,635 | 2,655 | -1 | ±0% | 71,600 |
2021/06/23 | 2,673 | 2,700 | 2,646 | 2,656 | -17 | -0.6% | 80,500 |
2021/06/22 | 2,617 | 2,673 | 2,609 | 2,673 | +84 | +3.2% | 127,800 |
2021/06/21 | 2,558 | 2,593 | 2,545 | 2,589 | +18 | +0.7% | 104,000 |
2021/06/18 | 2,604 | 2,616 | 2,558 | 2,571 | -33 | -1.3% | 103,100 |
2021/06/17 | 2,622 | 2,643 | 2,603 | 2,604 | -15 | -0.6% | 73,800 |
2021/06/16 | 2,580 | 2,624 | 2,562 | 2,619 | +16 | +0.6% | 58,900 |
2021/06/15 | 2,622 | 2,622 | 2,580 | 2,603 | -21 | -0.8% | 86,700 |
2021/06/14 | 2,585 | 2,658 | 2,582 | 2,624 | +50 | +1.9% | 136,700 |
2021/06/11 | 2,566 | 2,577 | 2,548 | 2,574 | +12 | +0.5% | 94,500 |
2021/06/10 | 2,548 | 2,570 | 2,536 | 2,562 | +14 | +0.5% | 129,500 |
2021/06/09 | 2,538 | 2,564 | 2,530 | 2,548 | +28 | +1.1% | 108,000 |
2021/06/08 | 2,510 | 2,546 | 2,503 | 2,520 | +11 | +0.4% | 93,700 |
2021/06/07 | 2,488 | 2,519 | 2,469 | 2,509 | +28 | +1.1% | 104,400 |
2021/06/04 | 2,486 | 2,495 | 2,470 | 2,481 | -17 | -0.7% | 123,600 |
2021/06/03 | 2,457 | 2,513 | 2,446 | 2,498 | +68 | +2.8% | 132,200 |
2021/06/02 | 2,420 | 2,463 | 2,410 | 2,430 | +23 | +1% | 159,500 |
2021/06/01 | 2,389 | 2,407 | 2,351 | 2,407 | +38 | +1.6% | 72,600 |
2021/05/31 | 2,350 | 2,400 | 2,340 | 2,369 | +23 | +1% | 91,800 |
2021/05/28 | 2,339 | 2,350 | 2,311 | 2,346 | +31 | +1.3% | 78,400 |
2021/05/27 | 2,300 | 2,345 | 2,300 | 2,315 | -14 | -0.6% | 122,200 |
2021/05/26 | 2,315 | 2,345 | 2,292 | 2,329 | -36 | -1.5% | 106,300 |
2021/05/25 | 2,390 | 2,408 | 2,361 | 2,365 | -31 | -1.3% | 97,600 |
2021/05/24 | 2,350 | 2,405 | 2,343 | 2,396 | +26 | +1.1% | 106,600 |
2021/05/21 | 2,345 | 2,380 | 2,332 | 2,370 | +30 | +1.3% | 89,100 |
2021/05/20 | 2,300 | 2,345 | 2,292 | 2,340 | +11 | +0.5% | 89,600 |
2021/05/19 | 2,300 | 2,330 | 2,280 | 2,329 | -1 | ±0% | 91,400 |
2021/05/18 | 2,266 | 2,348 | 2,259 | 2,330 | +14 | +0.6% | 148,900 |
2021/05/17 | 2,310 | 2,335 | 2,243 | 2,316 | +84 | +3.8% | 101,400 |
2021/05/14 | 2,237 | 2,328 | 2,220 | 2,232 | +29 | +1.3% | 59,400 |
2021/05/13 | 2,195 | 2,250 | 2,186 | 2,203 | -31 | -1.4% | 50,300 |
2021/05/12 | 2,292 | 2,292 | 2,230 | 2,234 | -64 | -2.8% | 73,700 |
2021/05/11 | 2,322 | 2,347 | 2,296 | 2,298 | -24 | -1% | 70,100 |
2021/05/10 | 2,284 | 2,327 | 2,277 | 2,322 | +38 | +1.7% | 48,900 |
951~
1000
件表示中 / 6968件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 312,500円 | +7.9% | -3.3% | 2.56% | 8.69倍 | 0.90倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 378,500円 | -6.4% | -71.8% | 5.02% | 42.15倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ゼリア新薬 | 204,600円 | +3.1% | -6.5% | 2.35% | 9.49倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 296,700円 | +5.1% | -7.0% | 2.70% | 19.48倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
市場注目の銘柄
チャート関連のコラム